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Functional genomic analysis of gene expression in
mice allowed us to identify a quantitative trait locus
(QTL) linked in trans to the expression of 190 gene
transcripts and in cis to the expression of only two
genes, one of which was Ypel5. Most of the trans-
expression QTL genes were interferon-stimulated
genes (ISGs), and their expression in mouse macro-
phage cell lines was stimulated in an IFNB1-depen-
dent manner by Ypel5 silencing. In human HEK293T
cells, YPEL5 silencing enhanced the induction of
IFNB1 by pattern recognition receptors and phos-
phorylation of TBK1/IKBKE kinases, whereas co-
immunoprecipitation experiments revealed that
YPEL5 interacted physically with IKBKE. We thus
found that the Ypel5 gene (contained in a locus linked
to a network of ISGs in mice) is a negative regulator
of IFNB1 production and innate immune responses
that interacts functionally and physically with TBK1/
IKBKE kinases.INTRODUCTION
Functional genomics, which evaluates the functional conse-
quences of genetic variations on intermediate molecular traits,
has been proposed as a means to improve the power of detect-
ing gene variants linked to complex traits (Nica and Dermitzakis,
2008). This approach is supported by increasing evidence
showing that gene regulatory changes often contribute to com-
plex phenotypes (such as susceptibility to disease; Pai et al.,
2015) and that a majority of genes have expression levels that
associate with genetic variants (Pierce et al., 2014). Quantitative
trait loci (QTLs) linked to gene expression are called expression
QTLs (eQTLs). Genetic variants may affect the expression of
genes that either map in their vicinity (cis-eQTLs) or reside further
away (trans-eQTLs) (Grieve et al., 2008). Heritability studies sug-
gest that trans-acting variants are responsible for more than halfC
This is an open access article under the CC BY-Nof the genetically explained variance in gene expression (Price
et al., 2011).
In some particular cases, genetic variants may associate in
trans with expression levels of a large number of genes, with
such clusters being commonly referred to as trans-eQTL hot-
spots (Breitling et al., 2008). Their functional interest is high-
lighted by the findings that (1) in some instances, they show
enrichment for functionally related genes (Grieve et al., 2008;
Emilsson et al., 2008; Kang et al., 2014), which may give insights
on how several genes in the network contribute to a biologic
function, and (2) trans-eQTL hotspots overlap significantly with
loci containing association signals for complex diseases (Westra
et al., 2013; Fehrmann et al., 2011; Fairfax et al., 2014).
The association of a single genetic variant to expression levels
of a large number of genes in trans suggests that genes in the
cluster are downstream of a common regulator. Studies testing
for enrichment of transcription factor (TF) binding sites within
the promoters of genes in trans-eQTL hotspots have led to the
identification of several TFs, including KLF4 (Small et al., 2011),
IRF2 (Fairfax et al., 2014), and Irf7 (Heinig et al., 2010), as
‘‘hub’’ genes within the trans-eQTL gene network. However,
the loci of the latter did not always correspond to that of the trans
eQTL (Heinig et al., 2010), indicating that trans-eQTL regions
may still contain cis-eQTL genes that may not be TFs but are
ultimately responsible for linkage of all trans-eQTL genes to their
locus. Alternatively, given the recent report that up to 43% of the
SNPs associated in trans with gene expression levels also
showed association with at least one local cis eQTL (Pierce
et al., 2014), all cis-eQTL genes whose locus matches that of
the trans eQTL could be considered as potential regulators of
trans-eQTL genes, independently of their ability to function
as TFs.
By analyzing gene expression profiles in mouse hearts, we
previously detected a trans-eQTL connected to 192 gene tran-
scripts (Imholte et al., 2013). Within the eQTL hotspot, two tran-
scripts (Ypel5 and Clip4) corresponded to genes conforming to
the definition of cis-eQTL genes (with transcription start sites
at <1 Mbp from the SNP). Based on preliminary data-mining an-
alyses, we prioritized Ypel5 for further investigation. We found
that Ypel5 negatively regulates interferon-b1 (IFNB1) productionell Reports 17, 425–435, October 4, 2016 ª 2016 The Authors. 425
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Chromosomal Distribution of eQTL Genes Linked either in
cis or in trans to rs33200140 on chr17
Total transcript count is shown for each chromosome, many of which are
interferon-stimulated gene (ISG) transcripts according to the Interferome v2.0
database. Genes in bold were those chosen for further functional character-
ization in subsequent experiments.via interactions with TBK1/IKBKE kinases. These findings illus-
trate the ability of this experimental strategy to discover genes
that code for regulators of larger gene networks, without any
prior knowledge of the biological function of these genes, and
are of interest to the biology of innate immune responses.
RESULTS
Characteristics of cis-eQTL and trans-eQTL Genes
We previously profiled gene expression in hearts from 24 A3B/
B3A mouse recombinant inbred strains (RISs) that originated
from reciprocal crosses between the parental C57BL/6J and
A/J strains (Scott-Boyer and Deschepper, 2013) and further
used that dataset to test the performance a newly developed
Bayesian eQTL analysis tool (Imholte et al., 2013). These tests
allowed us to find that the newmethod detected trans-eQTL hot-
spots containing a large number of genes with greater sensitivity
than more traditional univariate methods. In particular, the
largest trans-eQTL hotspot that was detected contained 190
genes linked in trans to a locus (identified as 17@72.4) at position
72.449 Mb on chromosome 17 (chr17), which corresponded to
the rs33200140 SNP. Thus, the abundance of the trans-eQTL
transcripts in RIS mouse hearts varied (in mice that all have
a mixed C57BL/6J 3 A/J genetic background) according
to whether ns33200140 originated from the parental A/J or
C57BL/6J strain. Yippee-like 5 (Ypel5) and Clip4 (at positions
72,851 Mb and 71,782 Mb, respectively) were the only eQTL
genes with a transcription start site located <1 Mbp from the
rs33200140 SNP and thus were the only two conforming to the
definition of cis-eQTL genes. The 190 trans-regulated transcripts
in the hotspot originated from loci distributed among all chromo-
somes (Figure 1), with 177 of them corresponding to genes with
official gene symbols.426 Cell Reports 17, 425–435, October 4, 2016The most statistically enriched categories of Gene Ontology
(GO) terms for the genes within the hotspot were those corre-
sponding to ‘‘immune responses,’’ ‘‘purine nucleotide binding,’’
and ‘‘antigen processing and presentation’’ (Table S1A). As
several of the hotspot genes corresponded to known ISGs, we
queried the ‘‘Interferome’’ database (Hertzog et al., 2011) and
found that 110 out of the 177 trans eQTLs with official gene sym-
bols corresponded to ISGs (Table S2). Among these genes, 22
were identified as responding exclusively to type I IFNs (IFN-a/
IFN-b), 8 were identified as responding exclusively to type II
IFNs (IFN-g), and 80 responded to both type I and type II IFNs.
Thus, 102 out of 177 genes within the hotspot were responsive
to type I IFN.
The eQTL cluster contained genes with a >1.4-fold difference
in expression in hearts from RIS mice (as a function of the allelic
origin of the chr17 locus).We profiled the pattern of expression of
these genes across cells and tissues, using data from the Bio-
GPS gene annotation portal (Figure S1). Euclidian clustering of
the expression level values of these genes revealed four groups
of cells and tissues. The highest levels of expression were found
in stimulated macrophages, followed by three groups with pro-
gressively declining levels. The first one comprised most im-
mune cells and tissues, the second one comprised mostly
CNS tissue cells and testes, and the lowest levels of expression
were found in remaining tissues and cells (Figure S1). In compar-
ison, expression of Ypel5 itself was fairly ubiquitous, but the
highest levels were found in stimulated macrophages and mast
cells, bone marrow, and CNS tissue.
The Ypel5 protein showed a high level of conservation across
vertebrates, as there was 100% identity at the amino acid level in
primates, rodents, bovines, and Xenopus (Figure S2A). Nonethe-
less, the only homologies detected by BLAST searches (either at
the nucleotide or amino acid level) were for genes/proteins con-
taining a Yippee-like domain (originally identified in Drosophila).
To go beyond linear sequence analogies, we tested possible
protein tridimensional (3D) homology/analogy using the Phyre2
recognition engine (Kelley and Sternberg, 2009). Only 13 tem-
plates had scores for 3D structural match with YPEL5 higher
than the suggested 80% threshold. Several of the templates
were the C-terminal portion (i.e., the regulatory domain) of
RIG-I/DDX58, MDA5/IFIH1, and LGP2/DHX58 proteins (from
multiple species), all of which were DExD/H box RNA helicases
belonging to the subfamily of the RIG-I-like receptor family
(RLRs) that play important roles in the control of IFN-b (IFNB1)
(Bruns and Horvath, 2014). YPEL5 shared with these proteins
(1) a similar succession of b strands and a helices and (2) the po-
sitions of four zinc-coordinating cysteine residues that form a
motif that is considered to be essential for the functions of these
proteins (Cui et al., 2008) (Figure S2B). Three other templates
corresponded toMSS4, a guanosine diphosphate (GDP)/guano-
sine triphosphate (GTP) exchange factor for small Rab-like
GTPases that shows 3D similarity in both fold and zinc cluster
with RIG-I/DDX58 (Cui et al., 2008).
Expression of Clip4 was more tissue specific than that of
Ypel5. The highest levels were found in skeletal muscle, mam-
mary gland, and cornea, medium levels were found in the
CNS, and very low levels were found in most other tissues. Like-
wise, Clip4 protein showed only partial homologies (both by
Figure 2. Ypel5 Negatively Regulates trans-eQTL Genes in RAW264.7 Cells in an Ifnb1-Dependent Manner
(A–F) Relative abundance of mRNA transcripts of Ifnb1, Bst2,Usp18, Irf7, Ifit3, andGbp2 in RAW264.7 cells transfected for 24 hr with siRNA (either scrambled or
specific for Ypel5 or Ifnb1, either alone or in combination). In cells transfected with Ifnb1 siRNA alone, Ifnb1 expression levels decreased to an average of 45% of
that observed in cells transfected with scrambled siRNA, and no further increase was observed after siYpel5 transfection. All values represent the means (±SD) of
results obtained in duplicate wells from four individual experiments (n = 8). The significance of differences was determined by one-way ANOVA followed by
Tukey’s multiple comparison post hoc tests (****p < 0.0001; ***p < 0.001).BLAST and Phyre2 searches) for restricted ankb24 or Cap-Gly
domains within other proteins. Given the predominance of
ISGs among trans-eQTL genes and the greater expression of
both Ypel5 and trans-eQTL genes in immune-related cells (in
particular macrophages), we considered Ypel5 to be a more
likely candidate regulator of the trans-eQTL genes than Clip4,
and we thus further tested whether Ypel5 silencing affected
the expression of trans-eQTL genes and/or Ifnb1 using mouse
macrophage-like cell lines for initial experiments.
Effects of Ypel5 Knockdown on trans-eQTL Genes in
Mouse Macrophage Cell Lines
Among the ISGs showing the largest differences in abundance
in hearts from mouse RISs (Table S2; Figure 1), we randomly
selected five genes (Bst2,Usp18, Irf7, Ifit3, andGbp2) and tested
the effects of Ypel5 silencing on their expression levels using
qRT-PCR. Both in RAW 264.7 and J774 cells, transfection with
specific Ypel5 small interfering RNA (siRNA) decreased Ypel5
expression to <30% of the levels found in cells transfected
with scrambled siRNA and significantly increased the expression
of all five tested ISGs, in addition to that of Ifnb1 itself (Figures
S3A and S3B). Additional experiments in RAW 264.7 cells
showed that the effects of Ypel5 siRNA on all five ISGs were
blocked when it was co-transfected with Ifnb1 siRNA (Figure 2),
suggesting that the responses of ISGs were in fact secondary to
increased expression of Ifnb1. Beyond baseline conditions, we
tested whether Ypel5 silencing affected the induction of Ifnb1
by either transfection with 25 ng poly(I:C) (which induces Ifnb1
via RLRs acting as intracellular RNA sensors) or exposure of cellsto 2,000 ng extracellular poly(I:C) (which induces Ifnb1 via Toll-
like receptor 3 [TLR3]). We verified previously that (1) 25 ng extra-
cellular poly(I:C) had no effect on Ifnb1, (2) the dose of 2,000 ng
was slightly above the threshold required for extracellular
poly(I:C) to affect Ifnb1 expression, (3) neither poly(I:C) treatment
affected endogenous Ypel5 expression, and (4) Ypel5 siRNA
downregulated Ypel5 expression to the same extent in all groups
(Figures S3C–S3E). Ypel5 silencing amplified the effects of both
poly(I:C) treatments on Ifnb1 induction (Figure 3). The specificity
of Ypel5 siRNA was further assessed in two different ways.
First, we verified that the Ypel5 siRNA had no effect on the
expression of two control genes, i.e., the Gapdh housekeeping
gene and Gpr183, a gene previously found to regulate expres-
sion of many inflammatory genes (Heinig et al., 2010) (Fig-
ure S3F). Second, we found that two additional Ypel5 siRNAs
affected endogenous Ypel5 expression to the same extent as
the first siRNA and that they both increased Ifnb1 production,
either in basal conditions or after induction with intracellular
poly(I:C) (Figures S3G–S3H).
To further explore the general effects of Ypel5 silencing in
macrophages, we compared the transcriptosomes of RAW
264.7 cells transfected with either scrambled or Ypel5 siRNA.
Si-Ypel5 affected the expression of a total of 944 gene tran-
scripts (p value < 0.005; false discovery rate [FDR] < 0.1),
including that of 50 genes belonging to the cardiac eQTL
hotspot. Enrichment analyses for GO terms within the 944 genes
revealed statistical enrichment for the ‘‘immune and defense
responses’’ and ‘‘nucleotide and ribonucleotide binding’’ cate-
gories (i.e., categories similar to those showing enrichment inCell Reports 17, 425–435, October 4, 2016 427
Figure 3. Ypel5 Downregulation Amplifies
the Effects of either Intracellular or Extracel-
lular Poly(I:C) on Ifnb1 Induction
Expression of Ifnb1 in RAW 267.4 cells transfected
with either scrambled or Ypel5 siRNA, either in
basal conditions or after transfection with 25 ng
poly(I:C) (left) or exposure to extracellular poly(I:C)
(2,000 ng/mL). All values represent the means
(±SD) of results obtained in replicate wells from
two individual experiments (n = 14). Significance of
differences was determined by two-way ANOVA
analysis. ****p < 0.0001 versus scrambled by
Tukey’s multiple comparison post hoc tests.genes showing differential expression in mouse RIS hearts), as
well as for the categories corresponding to ‘‘mitochondria’’ and
‘‘regulation of programmed cell death’’ (Table S1B). Among all
gene transcripts affected by Ypel5 silencing, 248 and 65 of
them were either up- or downregulated by >30%, respectively,
altogether corresponding to a total of 281 genes with official
gene symbols. Among the latter, 160 out of 281 genes (57%)
were reported as ISGs in the Interferome database. When exam-
ining the 50 trans-eQTL genes showing >40% differences in
mouse RIS hearts and testing whether Ypel5 silencing affected
their expression in RAW264.7 cells, we found that this was the
case for 26 out of 50 (i.e., 52%) (Table S3). Altogether, these re-
sults showed that mouse RIS hearts expressed a core of IFNB1-
responsive genes (1) whose expression levels were associated
with differences in Ypel5 expression and (2) that overlapped
with genes whose expression was affected by Ypel5 silencing
in RAW264.7 cells.
Effects of YPEL5 on IFNB1 Induction in Human Cells
We further tested whether YPEL5 silencing would have a similar
effect on IFNB1 induction in human cells as in the mouse macro-
phage cell lines. We chose the HEK293T cell line because it has
been the preferred model in most previous studies on IFNB1-
regulating pathways and because we previously used this line
to identify many potential modulators of the tightly regulated pro-
duction of IFNB1 (Baril et al., 2013). Sendai virus (SeV) is an RNA
virus that is recognized by RIG-I, leading to IFNB1 production and
upregulation of ISGs (Yoo et al., 2014; Rehwinkel et al., 2010). The
effects of SeV infection on induction of RIG-I andMDA5 (tested as
representative ISGs) were amplified by YPEL5 downregulation
(Figures 4A–4C) and dampened by YPEL5 overexpression (Fig-
ure 4D–4F). After SeV infection, there was a time-dependent in-
crease in the expression of the mRNAs of IFNB1 and that of
SeV nucleocapsid (NP) protein. These responses were either
amplified (Figure 4G) or dampened (Figure 4H), respectively, by
YPEL5 downregulation. Si-YPEL5 also amplified the effects of
SeV on IFNB1-dependent luciferase activity in transfected cells
(Figure S4A). At no time after infection did we notice any change
in endogenous YPEL5 expression levels compared to scrambled
siRNA-transfected cells (Figure S4B).
After sensing and binding to either non-self or 50-ppp viral
RNA, RLRs undergo conformational changes that allow them428 Cell Reports 17, 425–435, October 4, 2016to interact with MAVS at the mitochondrial outer membrane
(Yoo et al., 2014). Binding of RIG-I and/or MDA5 to 50-ppp
RNA depends on the presence of several critical lysine residues
in their regulatory domains (Wang et al., 2010), but these resi-
dues were not conserved into the YPEL5 sequence (Figure S2).
Moreover, we verified experimentally that YPEL5 did not share
with RIG-I the ability to bind to either hepatitis C virus (HCV)
RNA or poly(I:C) (a synthetic mimetic of double-stranded RNA)
(Figure S5). Despite these differences, we tested whether
YPEL5 downregulation could affect signaling events initiated
by activated RLRs. In HEK293T cells transfected with pIFNB1-
LUC, YPEL5 siRNA significantly amplified the induction of
IFNB1-dependent luciferase activity by overexpression of either
activated RIG-I (Figure 5A) or of effectors acting downstream of
viral RNA sensing (i.e., MAVS, TBK1, or IKBKE) (Figures 5B–5D).
In addition, YPEL5 downregulation enhanced the luciferase-
inducing effects by two other nucleic-acid-sensing systems
that activate TBK1/IKBKE kinases independently of MAVS, i.e.,
TRIF, which mediates the effects of stimulated TLR3 (Park
et al., 2010), and the cGAS/STING cytosolic DNA sensor system
(Sun et al., 2013) (Figures 5E and 5F). One of the other reported
effects of activated TBK1/IKBKE kinases is their ability to trigger
phosphorylation events that lead to nuclear factor kB (NF-kB)
activation (Shen and Hahn, 2011). Accordingly, we found that
YPEL5 downregulation enhanced the effects of TBK1/IKBKE
overexpression on the induction of endogenous TNF, a well-
known target of NF-kB (Figure S6). Moreover, YPEL5 silencing
increased the effects of overexpressed TBK1 on its auto-phos-
phorylation and the effects of overexpressed IKBKE on its
auto-phosphorylation and the cross-phosphorylation of TBK1
(Figure 6). To test possible physical interactions of YPEL5, we
co-transfected HEK293T cells with both 3X-FLAG-YPEL5
and constructs expressing MAVS, TBK1, or IKBKE. Western
blots performed on material immunoprecipitated with anti-
FLAG antibody revealed that the precipitates contained immu-
noreactivity for IKBKE, but not for eitherMAVSor TBK1 (Figure 7).
These results were confirmed in reverse experiments, where
HEK293T cells were co-transfected with YPEL5-Myc and con-
structs expressing FLAG-tagged YFP, TBK1, or IKBKE (Fig-
ure S7). Altogether, the results showed that YPEL5 interacts
physically with IKBKE and functionally with the activity of
TBK1/IKBKE kinases. However, YPEL5 downregulation also
Figure 4. Effects of YPEL5 Downregulation
or Overexpression in HEK293T Cells with
or without SeV Infection
(A–C) Immunoblot analyses of HEK293T cells
transfected with combinations of scrambled and
YPEL5 siRNA (8 pmol scrambled, 4 pmol scram-
bled and 4 pmol si-YPEL5, or 8 pmol si-YPEL5) for
32 hr and then infected (or not) with SeV for 16 hr.
Immunoblotting for actin shows that equivalent
amounts of proteins were loaded in each well. The
blots are representative results of one experiment
(A). Quantification of the results obtained in
replication experiments is as shown in (B) and (C)
(n = 3).
(D–F) Immunoblot analyses of HEK293T trans-
fected with either 3XF-MCS (empty plasmid) or the
3XF-YPEL5 expression plasmid for 32 hr and then
infected (or not) with SeV for 16 hr. Immunoblotting
with the FLAG antibody shows that the 3x-FLAG
proteins are correctly expressed. The blots are
representative results of one experiment (D).
Quantification of the results obtained in replication
experiments are as shown in (B) and (C) (n = 3).
(G and H) qRT-PCR analyses of the mRNA abun-
dance of either IFNB1 (C) or SeV NP (D). The ex-
tracts came from HEK293T cells transfected
with either scrambled or YPEL5 siRNA for 24 hr
and further infected with SeV for 12, 24, 36, or
48 hr. The results of two-way ANOVA analyses are
indicated.increases INFB1-mediated ISG56 luciferase activity in cells that
are respectively exposed to recombinant (rc)IFNB and overex-
pression of IRF3(5D), a phosphomimetic mutant of IRF3 that
partially mimics virus-induced IRF3 activation (Figure S8).
The effects of YPEL5 downregulation were validated in two
different ways. We first verified that the effects of two additional
YPEL5 siRNAs on expression of endogenous YPEL5were similar
to that of the first siRNA tested and amplified the effects of TBK1
on IFNB1-dependent luciferase activity to a similar extent (Fig-
ure S9). We also ablated YPEL5 in HEK293T cells by an RNA-
guided nuclease approach and selected two clonal cell lines,
with the absence of YPEL5 being verified by qRT-PCR (Fig-
ure S10). YPEL5 ablation was accompanied by a significant in-
crease in IFNB1- and NF-kB-dependent activity (Figures S10C
and S10D), along with increases in the expression of endoge-
nous RIG-I (a target of IFNB1) and endogenous TNF (a targetCellof NF-kB) (Figures S10E and S10F). Like-
wise, TBK1 overexpression increased
IFNB1-LUC activity to a greater extent
in the clones with YPEL5 ablation
(Figure S10C).
DISCUSSION
In light of recent studies showing overlap
of many trans-eQTL hotspots with loci
containing association signals for com-
plex diseases (Westra et al., 2013; Fehr-
mann et al., 2011; Fairfax et al., 2014), abetter understanding of the mechanisms controlling the expres-
sion of trans-eQTL genes would be helpful to elucidate the
causes of complex disorders. Until now, the number of trans-
eQTL hotspots reported in the literature is small, with tentative
explanations being that effect sizes are typically modest, that
multiple testing procedures create a particular statistical burden,
and/or that trans-eQTLs are in general more sensitive to the ef-
fects of confounding factors (Kang et al., 2008; Breitling et al.,
2008; Westra et al., 2013). Nonetheless, three recent develop-
ments promise to facilitate the detection of trans-eQTL hotspots:
(1) the pooling of the results of several studies, which may
improve statistical power by allowing eQTL meta-analyses
(Westra et al., 2013); (2) the design of studieswhere gene expres-
sion is studied in cells across several experimental conditions, in
order to detect context-dependent eQTLs (Fairfax et al., 2014);
and (3) improvements in the computational methods used toReports 17, 425–435, October 4, 2016 429
Figure 5. YPEL5 siRNA Potentiates the Induction of IFNB1-Dependent Luciferase Activity by Signaling Events that Activate TBK1/IKBKE
Kinases
24 hr after transfection with YPEL5-specific siRNA, HEK293T cells were co-transfected with the pIFNB1-LUC reporter plasmid, along with either pcDNA3.1
(empty plasmid) or expression plasmids for RIG-I, MAVS, TBK1, IKBKE, TRIF, or cGAS-STING. Luciferase activity was measured 24 hr after transfection.
All values represent the means (±SD) of results obtained in replicate wells from three to four individual experiments (n = 16–24). Interactions between the effects
of the stimuli with that of the siRNAs were tested by two-way ANOVAs, and the significance values of the interactions between si-YPEL5 and stimuli are
indicated. Asterisks indicate significant differences between cells transfected with either scrambled or YPEL5 siRNA, as determined by Tukey’s pot-hoc tests
(****p < 0.0001; **p < 0.01).detect trans eQTLs, including the use of Bayesian approaches
(Petretto et al., 2010; Scott-Boyer et al., 2012). The eQTL hotspot
reported herein was detected using such a multivariate compu-
tational tool (Imholte et al., 2013). It contained 190 trans-regu-
lated and two cis-regulated transcripts, among which we priori-
tized Ypel5 as a possible candidate regulator on the basis of
data-mining queries. The family of YPEL proteins has been re-
ported in essentially all eukaryotes (including fungi, plants, and
unicellular organisms), and all members show very high levels
of evolutionary conservation, which altogether suggest impor-
tant functions for these proteins (Hosono et al., 2004, 2010).
However, functions of YPEL5 have been limited to a possible
participation in events related to cell-cycle progression (Hosono
et al., 2004, 2010).
Outside of the family of YPEL proteins, YPEL5 showed no ho-
mology with the linear amino acid sequences of any other known
mammalian protein, but at the structural 3D level, it showed
some homology with the regulatory domain of three RLRs.
YPEL5 shared with these proteins the positions of four zinc-
coordinating cysteine residues that form a motif considered to
be a typical structural element of this protein family (Cui et al.,
2008). Although we found no evidence that YPEL5 could (in
contrast to RIG-I) bind to viral RNA, there are precedents for430 Cell Reports 17, 425–435, October 4, 2016RLR-related proteins being able to play roles other than just
RNA sensing and to interact with further downstream signaling
components. For instance, LGP2 (an homolog of RIG-I and
MDA5) inhibits IFN by acting both upstream and downstream
of MAVS (Komuro and Horvath, 2006). Likewise, DDX3 and
SNRNP200 (which both belong to the family of DExD/H box
RNA helicases) enhance the phosphorylation of IRF3 and the
production of IFNB1 via specific interactions with IKBKE and
TBK1, respectively (Gu et al., 2013; Tremblay et al., 2016). Since
most genes in the trans-eQTL hotspot were also known ISGs, we
tested the hypothesis that YPEL5 could play a role in IFNB1
regulation. Our data indicate that downregulation of Ypel5 by
three different siRNAs enhances Ifnb1 production in mouse
macrophage cell lines. In human HEK293T cells, (1) downregula-
tion of Ypel5 by three different siRNAs enhances Ifnb1 produc-
tion, and this effect is accompanied by a decrease in SeV repli-
cation in infected cells; (2) the effects of clustered regularly
interspaced short palindromic repeats (CRISPR)/Cas9-medi-
ated deletion of YPEL5 on IFNB1-dependent responses are
similar to that of YPEL5 downregulation; and (3) the effects of
overexpressed YPEL5 in HEK293T on ISGs are the reverse im-
age of those obtained with YPEL5 downregulation. It remains
to be seen to which extent YPEL5 affects the expression of
Figure 6. YPEL5 Silencing Increased the
Effects of Overexpressed IKBKE and TBK1
on Their Respective Auto- or Cross-phos-
phorylation
HEK293T cells treated with either scrambled or
YPEL5 siRNA for 24 hr and then transfected for an
additional 24 hr with either pcDNA3.1 (empty
plasmid) or expression plasmids for either TBK1 or
IKBKE. Phosphorylation levels at Ser172 were
determined by calculating the ratio of the signals
obtained with phospho-specific antibodies versus
that obtained with antibodies against total pro-
teins. The levels observed in wells transfected with
siYPEL5 showed no overlap with the lower levels
observed in cells transfected with scrambled
siRNA. The charts on the right show the results
obtained in three replicate experiments.inflammatory genes in other cell types and/or genetic back-
grounds. For instance, several of the trans-eQTL genes whose
expression was associated with the allelic origin of the chr17
locus in RIS mice (i.e., in mixed C57BL/6J 3 A/J genetic back-
grounds) did not show significant differences in hearts from the
parental inbred strains themselves (data not shown). The full ef-
fects of YPEL5 may therefore either be modulated by additional
factors and/or be partly dependent on them.
TBK1 and IKBKE kinases are non-canonical members of the
IKK family and play a critical role in type 1 (and III) IFN responses
via their ability to phosphorylate and activate IRF3 (Hutti et al.,
2012). In HEK293T cells, YPEL5 silencing enhances the effects
of overexpression of (1) TBK1 and IKBKE, (2) MAVS or RIG-I
(which activates MAVS upstream of TBK1/IKBKE kinases), or
(3) TRIF or cGAS-STING (two additional adaptors that lead to
activation of TBK1/IKBKE kinases). Results of co-immunopre-
cipitation (coIP) experiments indicated that YPEL5 protein inter-
acted physically with material containing IKBKE immunoreac-
tivity. That physical interaction had likely effects of TBK1/
IKBKE kinases themselves, since si-YPEL5 enhanced the effects
of overexpressed TBK1 and IKBKE on (1) their auto- and cross-
phosphorylation (i.e., two covalent modifications that participate
in their activation) (Ma et al., 2012); and (2) the induction of
endogenous TNF, a well-known target of NF-kB that itself is acti-
vated by the phosphorylation of TBK1/IKBKE kinases (Shen and
Hahn, 2011). Other effects of YPEL5 may need further investiga-
tion but are not incompatible with possible involvement of TBK1/
IKBKE kinases. For instance, the fact that the assembly of the
multimeric STAT1/STAT2/IRF9 complex is facilitated by the
effect of IKBKE on STAT1 (Ng et al., 2011) might explain whyCellYPEL5 downregulation amplifies the ef-
fect of rcIFNB1. Likewise, the amplifica-
tion of the effect of IRF3(5D) by siYPEL5
might be explained by the fact that TBK1
directly phosphorylates MAVS, STING,
and MAVS to allow the latter to recruit
IRF3 for phosphorylation on residues
that are different from those whose phos-
phorylation are mimicked in IRF3(5D) (Liu
et al., 2015).
Despite the difficulties of detecting trans-eQTL hotspots,
most of the ones detected to date concern inflammatory genes
(Westra et al., 2013; Fehrmann et al., 2011; Fairfax et al., 2014;
Heinig et al., 2010). Since inflammatory responses typically
implicate coordinated responses of many genes, such net-
works may constitute those where genetic variants are most
likely to associate with trans-eQTL hotspots and explain why
the latter often overlap with loci containing association signals
for complex diseases. In mouse RIS hearts (where the Ypel5
locus is linked to the expression of the trans-eQTL genes),
QTL-dependent differences in gene expression may be due to
differences either in cardiomyocytes themselves or in other
cell types (including resident or infiltrating macrophages).
Regardless of the cell type, the pathways regulated by Ypel5
have been implicated in cardiac pathophysiology. For instance,
several IFN regulatory factors play critical roles in the modula-
tion of left ventricular remodeling (Tsushima et al., 2011; Jiang
et al., 2013, 2014a). Likewise, invalidation of the IKBKE gene
in mice leads to cardiac hypertrophy, fibrosis, and cardiac
dysfunction, indicating a crucial role for IKBKE in regulating car-
diac hypertrophy (Dai et al., 2013).
In addition to their IFNB1 regulatory properties, both TBK1 and
IKBKE promote oncogenesis (Guo et al., 2009; Barbie et al.,
2009; Boehm et al., 2007). IKBKE is frequently overexpressed
in a number of human cancers, in particular breast, ovarian,
and pancreatic cancer (Verhelst et al., 2013), and inhibition
of either kinase suppresses the growth of HER2-driven breast
cancer (Jiang et al., 2014b). Of note, TBK1 is constitutively
expressed in most cell types, whereas basal IKBKE expression
is observed in specific tissues and cell types and is rapidlyReports 17, 425–435, October 4, 2016 431
Figure 7. YPEL5 Interacts Physically with IKBKE in Transfected
Cells
HEK293T cells were transfected with either FLAG-YFP (negative control) or
3xFLAG-YPEL5, as well as IKBKE-myc-, TBK1-myc-, or myc-MAVS-express-
ing plasmids for 32 hr. Cells were either uninfected (SeV) or infected (SeV+)
with SeV. After another 16 hr, immunoprecipitation was performed using anti-
FLAG antibodies. Either cell extracts (lysate) or eluates from immunoprecipi-
tated complexes (IP FLAG) were analyzed by western blotting. The images are
representative images of results obtained in three replicate experiments.inducible by cytokines (Verhelst et al., 2013). Although IKBKE
and TBK1 show many overlapping activities that are relevant
to innate immunity and inflammation, themore restricted expres-
sion of IKBKE might be of a particular interest in regards to its
regulation by YPEL5. It will thus be important to further determine
the regulatory role of YPEL5 with the relative contribution of
IKBKE and TBK1 in different pathways (e.g., NF-kB versus
IRF3) and pathophysiological processes.
In summary, biological validation of genomic analyses allowed
us to discover that Ypel5 is a negative regulator of the IFNB1 pro-
duction and innate immune responses, and that it acts primarily
at the level of TBK1/IKBKE kinases. Although the function of this
gene in vertebrates was not known, its high level of evolutionary
conservation suggested that it may play important roles.
Interestingly, it is an ortholog of Yippee in Drosophila, where it
interacts with hemolin (Roxstro¨m-Lindquist and Faye, 2001), a
protein that participates in anti-viral processes in insects (Tere-
nius, 2008). It is thus possible that the Yippee orthologs that
have evolved in vertebrates have been co-opted for other innate
immune responses.
EXPERIMENTAL PROCEDURES
Animals and Ethics Statement
Results of gene expression studies were obtained in hearts from a panel of 24
male A3B/B3A recombinant inbred mice, as described previously (Imholte
et al., 2013; Scott-Boyer and Deschepper, 2013). In these previous studies,
animals were euthanized by cervical dislocation, following approval by the an-
imal ethics committee of the Institut de Recherches Cliniques de Montre´al432 Cell Reports 17, 425–435, October 4, 2016(IRCM) and in agreement with the guidelines of the Canadian Council for Ani-
mal Care.
Cells Lines and Culture
RAW 264.7 and J774 cells (mouse monocytic/macrophagic cells) and
HEK293T (human embryonic kidney) cell lines were cultured in DMEM
(Wisent), supplemented with 10% fetal bovine serum, 100 U/mL penicillin,
100 mg/mL streptomycin, and 2 mM glutamine (all from Wisent).
For siRNA transfections, the scrambled MISSION siRNA SIC001 (Sigma-Al-
drich) was used as a negative control. For silencing mouse Ypel5, three
separate specific siRNAs were obtained: SASI_Mm01_00066332, SA-
SI_Mm01_00066328, and SASI_Mm01_00066329 (identified in the text as
si-Ypel5-1, si-Ypel5-2, and si-Ypel5-3, respectively). For silencing human
YPEL5, three separate specific siRNAs were obtained: SASI_Hs02_00329464,
SASI_Hs02_00329465, and SASI_Hs02_00329466. For mouse Ifnb1,we used
the SASI_Mm01_00145086 siRNA.
Transfection of siRNAs was performed using either HiPerfect reagents
(QIAGEN) in mouse cells or Lipofectamine RNAi-Max (Life Technologies) in
human cell lines, according to each manufacturer’s instructions. Transfection
of plasmids in human cells was performed with Lipofectamine 2000 (Life Tech-
nologies). For western blot experiments, cells were infected with 120 HAU/mL
Sendai virus (Cantell strain, Charles River Laboratories), as described previ-
ously (Baril et al., 2013).
Expression Vectors
Expression plasmids containing the sequences coding for either cGAS or
STING, as well as plasmids containing the sequences coding for either
EYFP, MAVS, TBK1, IKBKE, or IRF3(5D), all in frame with sequences coding
for the FLAG or Myc epitopes, as described previously (Es-Saad et al.,
2012; Baril et al., 2009). The plasmid for expression of the 3xFLAG-YPEL5
fusion protein was constructed by adding three consecutive FLAG repeats
to the N-terminal end of the Ypel5 coding sequence (amplified by PCR from
a cDNA) and cloning the product into pcDNA3.1.
Structural Protein Homology Analysis
Sequences were input into protein homology/analogy recognition engine
(Phyre) version 0.2 (http://www.sbg.bio.ic.ac.uk/phyre/). Threading analysis
was performed with the Phyre algorithm (Kelley and Sternberg, 2009) to iden-
tify templates bearing structural homology to YPEL5.
Gene Expression Analyses
Total RNA was extracted from harvested cells using RNA Microextraction kits
(QIAGEN). RNA concentrations were quantified by measuring absorbance at
260 nm and 280 nm with a Nanodrop apparatus (Thermo Scientific). Analysis
of the relative expression of specific genes versus that of the normalizing
Rps16 housekeeping gene was performed by qRT-PCR. In short, we calcu-
lated DCt values (Ct gene  Ct Rps16), and values for normalized transcript
abundance were expressed as 2(DCt). Primers used are listed in Table S4.
Gene expression profiling in transfected RAW264.7 cells was performed using
Illumina MouseRef-8 v2.0 BeadChips. Results were analyzed using the two-
sample Bayesian t test for microarray data (Fox and Dimmic, 2006), using
p < 0.005 and FDR < 0.1 as cutoff thresholds.
Luciferase Assays
293T cells were cultured in white opaque 96-well plates with complete phenol-
red-free DMEM. The following day, cells were transfected with 1.8 pmol siRNA
(either siYPEL5 or universal negative control). 24 hr after siRNA transfection,
cells were transfected with one of the several expression plasmids, along
with one of the luciferase reporter constructs; i.e., pIFNB1-LUC, pISG56-
LUC or p2xNF-kB-LUC (Baril et al., 2013). Cells were lysed 24 hr after the
second transfection, and luciferase activities were determined using a dual-
luciferase reporter assay system (Promega).
Western Immunoblot Analyses
Protein extracts were boiled for 5 min. Samples were separated on SDS-
PAGE gel and transferred to either nitrocellulose or polyvinylidene difluoride
membranes. Protein signals were detected using the Western Lighting
Chemiluminescence Reagent Plus (PerkinElmer). Each experiment was re-
peated at least three times. Primary antibodies used for western blot analyses
were as follows: anti-RIG-I (ALX-210-932-C100; Alexis Biochemicals), anti-
MDA5 (210-935-c100; Alexis Biochemicals), anti-actin (MAB1501, Chemicon
International), anti-FLAG (F3165; Sigma), anti-myc (SC-040; Santa Cruz
Biotechnology), anti-TBK1(SC-52957; Santa Cruz), anti-IKBKE (SC-365830;
Santa Cruz), anti-phospho-TBK1 (Ser172) (5483; Cell Signaling Technology),
and anti-phospho-IKBKE (Ser172) (8766; Cell Signaling Technology).
Co-immunoprecipitation
HEK293T cells were co-transfected with 5 mg 3xFlag-YPEL5 or YFP-FLAG,
along with 5 mg of an expression plasmid of Myc-tagged sequences of IKBKE,
TBK1, or MAVS. 32 hr later, cells were infected (or not) with 100 mL containing
600 HAU/mL SeV (Cantell Strain, Charles River Laboratories), as described
previously (Baril et al., 2013). After another 16 hr, cells were harvested and
lysed, and the concentration of total proteins in the lysates was adjusted to
1 mg protein/mL. The lysates were precleared by incubation for 1 hr with
40 mL of a slurry of immunoglobulin G-Sepharose (GE Healthcare) and incu-
bated overnight with agitation at 4C in the presence of 20 mL M2 anti-FLAG
affinity gel (Sigma-Aldrich). After centrifugation, the immunoprecipitates
were washed five times in lysis buffer, and elution was performed by incuba-
tion in the presence of purified FLAG peptide (250 ng/mL) (Sigma-Aldrich) for
45 min at 4C. The eluates were analyzed by western immunoblotting. For
reverse coIP, the cells were transfected with YPEL5-Myc along with FLAG-
tagged YFP, TBK1, and IKBKE.
Biotin-RNA Pull-Down Assay
Biotin-labeled poly(I:C) RNA was purchased from InvivoGen. Biotin-HCV RNA
was obtained by subjecting linearized HCV DNA to T7 reverse transcription
(TranscriptAid T7 High Yield, Life Technologies) and biotin-dUTP (Enzo Life
Sciences). HEK293T cells were transfected with either 3xFlag-YPEL5 or
RIG-I expression plasmids or the control 3xFlag-MCS (empty plasmid) for
32 hr, then treated with either SeV or vehicle for 16 hr. For the RNA pull-
down, Dynabeads M270 Streptavidin (Life Technologies) were incubated
with the biotin-labeled RNA substrates for 15 min with agitation at room tem-
perature and then incubated for 1 hr with agitation at 4C with aliquots of cell
lysates containing a total of 100 mg protein. After magnetic isolation, the beads
were washed three times, RNA-bound proteins were eluted by boiling in 0.1%
SDS, and the eluates were analyzed by western blot.
Ablation of the YPEL5 Gene in HEK293T Cells by RNA-Guided
Nuclease Technology
Guide RNA sequenceswere designed to target two sites in four of hYPEL5 and
cloned into the pSPCas9(BB)-2A plasmid, as described previously (Ran et al.,
2013). Transfection of the resulting plasmids into HEK293T cells caused
genomic deletions of 164 bp in exon 4 (between positions 30,158,609 and
30,158,772 in chromosome 2). Single-cell clones were isolated by clonal dilu-
tion of the transfected cells. To screen for clonal cell lines harboring the appro-
priate deletions, PCR amplification of the genomic DNA was performed using
primers flanking the deletion sites. Invalidation of YPEL5was further confirmed
by verifying (by qRT-PCR) that YPEL5 was no longer expressed at detectable
levels in the selected clonal lines.
Statistics
According to the specifics of each experiment, comparisons between groups
were performed using the Student’s t tests or one-way or two-way ANOVAs.
ANOVA analyses were followed by Tukey’s multiple comparison tests.
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